Wendy Grey - 19 Aug 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
10%+ Owner
Signature
/s/ Heidi Steele as attorney-in-fact for Wendy Grey
Issuer symbol
OCEL
Transactions as of
19 Aug 2022
Transactions value $
$0
Form type
3
Filing time
16 Sep 2022, 15:27:10 UTC
Next filing
15 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OCEL Common Stock 50,000,000 19 Aug 2022 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCEL Warrant 19 Aug 2022 Common Stock 150,000,000 $0.0200 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities issued to Greyt Ventures, LLC by Issuer. Greyt Ventures, LLC is owned by a trust for which the Ms. Grey is trustee.

Remarks:

Exhibit List - Exhibit 24 Power of attorney